Cargando…
Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden
OBJECTIVES: To assess if mammographic density (MD) changes during neoadjuvant breast cancer treatment and is predictive of a pathological complete response (pCR). METHODS: We prospectively included 200 breast cancer patients assigned to neoadjuvant chemotherapy (NACT) in the NeoDense study (2014–201...
Autores principales: | Skarping, Ida, Förnvik, Daniel, Heide-Jørgensen, Uffe, Sartor, Hanna, Hall, Per, Zackrisson, Sophia, Borgquist, Signe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375568/ https://www.ncbi.nlm.nih.gov/pubmed/32563178 http://dx.doi.org/10.1016/j.breast.2020.05.013 |
Ejemplares similares
-
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
por: Skarping, Ida, et al.
Publicado: (2019) -
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
por: Skarping, Ida, et al.
Publicado: (2020) -
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
por: Skarping, Ida, et al.
Publicado: (2021) -
Effects of statin use on volumetric mammographic density: results from the KARMA study
por: Skarping, Ida, et al.
Publicado: (2015) -
Mammographic density in relation to breast cancer recurrence and survival in women receiving neoadjuvant chemotherapy
por: Zdanowski, Anna, et al.
Publicado: (2023)